Mesothelioma.com Resources for Patients and their Families
Request Free Guide

Mesothelioma Doctors

Helen J. Ross, MD

Dr. Ross
Phoenix, AZ

Dr. Helen J. Ross

Medical Oncologist

Mayo Clinic Hospital

5777 East Mayo Boulevard
Phoenix, AZ 85054
480.342.2000

Need Help Contacting This Doctor?

Dr. Helen J. Ross is a medical oncologist with expertise in treating esophageal cancer, lung cancer, and mesothelioma who practices at the Mayo Clinic Hospital in Phoenix with a second office at the Mayo Clinic in Scottsdale. Dr. Ross has been practicing medicine for over 20 years, and continues to be an avid researcher to develop new treatments and treatment modalities to improve patient survival rates and quality of life.

Dr. Ross has authored and co-authored over 60 medical studies, book chapters and articles found in numerous medical journals, including the Annals of Thoracic Surgery. Her areas of research have included chemotherapy drugs for lung conditions, new chemotherapy combinations for peritoneal mesothelioma and stereotactic body radiotherapy for recurrent cancers.

Main Specialty: Oncology

Other Interests & Specialties: Lung cancer, malignant mesothelioma, esophageal cancer, multimodality therapy and clinical trials.

Certifications, Awards & Accolades: American Board of Internal Medicine Certifications in Medical Oncology and Internal Medicine, Top Oncologist in Phoenix and Scottsdale by the International Association of Oncologists, Top Presenters in Arizona Merit Award from Mayo School of Continuous Professional Development

Education & Experience:

Publications:
Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: outcomes of an expanded access program. National Center for Biotechnology information. February 2007;55(2):187-94. doi: 10.1016/j.lungcan.2006.09.023

Pemetrexed alone or in combination with cisplatin in previously treated malignant pleural mesothelioma: outcomes from a phase IIIB expanded access program. National Center for Biotechnology information. July 2006;1(6):506-12.

Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program. National Center for Biotechnology information. July 2005;7(1):40-6. doi: 10.3816/CLC.2005.n.020

Author: Linda Molinari

Editor in Chief, Mesothelioma Cancer Alliance

Linda Molinari

Reviewer: Annette Charlevois

Patient Support Coordinator

Annette Charlevois
Share
Tweet
Share
Packet

Top Mesothelioma Doctors

Please fill in the form below to request help contacting a mesothelioma specialist. We will respond promptly to your inquiry.

Have you or someone you know been diagnosed with mesothelioma?

Connect With A Mesothelioma Specialist:

Legal Rights Information Guide Free Guide Request Free Guide Free Mesothelioma Guide Free 2019 Mesothelioma Guide